Comparative in vitro activities of trovafloxacin (CP 99,219) and other antimicrobials against clinically significant anaerobes.

Lignende værker

• Pharmacokinetics and penetration into inflammatory fluid of trovafloxacin (CP-99,219).
  af: Wise, R, et al.
  Udgivet: (1996)
• Dose-ranging study of CP-99,219 (trovafloxacin) for treatment of uncomplicated gonorrhea.
  af: Hook, E W, et al.
  Udgivet: (1996)
• Comparative in vitro activities of trovafloxacin (CP-99,219) against 221 aerobic and 217 anaerobic bacteria isolated from patients with intra-abdominal infections.
  af: Citron, D M, et al.
  Udgivet: (1997)
• Pharmacokinetics of trovafloxacin (CP-99,219), a new quinolone, in rats, dogs, and monkeys.
  af: Teng, R, et al.
  Udgivet: (1996)
• Comparative in vitro activities of trovafloxacin (CP-99,219) against 445 gram-positive isolates from patients with endocarditis and those with other bloodstream infections.
  af: Endtz, H P, et al.
  Udgivet: (1997)